This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Ecole Pratique Des Hautes Etudes, Institut National De La Sante Et De La Recherche Medicale. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 138 
1 out of 6 
1 out of 13 
Years Active: 2026
Title: Jacques Bricard: Innovator in Medical Research
Introduction: Jacques Bricard is an inventor based in Illkirch-Graffenstaden, France. He has made significant contributions to the field of medicine, particularly in the area of central nervous system disorders. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical treatments.
Latest Patent Applications: Jacques Bricard's latest patent applications include "Sigma-1 Receptor Ligands and Therapeutic Uses Thereof." This invention relates to compounds that are sigma-1 receptor agonists and their use for the treatment of central nervous system disorders, including cognitive or neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, and multiple sclerosis. Another application is titled "Sigma-1 Receptor Ligands and Uses Thereof," which covers similar therapeutic uses.
Conclusion: Jacques Bricard's innovative work in the medical field highlights his dedication to addressing significant health challenges. His research on sigma-1 receptor ligands may pave the way for new treatments for debilitating disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile